2016 American Transplant Congress Archives - Page 53 of 180

Effect of Inflammation on Concentration of Intracellular Tacrolimus.

E. Bae,¹ S. Yang,² S. Han,¹ J.-Y. Park,¹ H. Lee,¹ Y. Kim.¹
Effect of Isolated Intraperitoneal Sirolimus Treatment on the Kidneys of C57BL/6 Mice.

B. Kim,^1,3 Y. Cho,³ H. Lee,³ D. Joo,^2,3 K. Huh,^2,3 M. Kim,^2,3 Y. Kim.^2,3
Effect of Modifying Life Support Withdrawal Practices on Outcomes of Donation After Circulatory Death in Liver Transplantation: A Meta-Analysis.

Y. Cao,^1,2 S. Shahrestani,³ H. Chew,^2,4 M. Crawford,⁵ P. Macdonald,^1,2,4 J. Laurence,^3,5,7 W. Hawthorne,^3,6 K. Dhital,^1,2,4 H. Pleass.^3,5,6
Effect of mTOR Inhibitors on the Risk of Cancer Development After Kidney Transplantation in Chinese Population.

C.-C. Kao,¹ J.-S. Liu,² M.-H. Lin,² F.-C. Chang,¹ Y.-C. Lin,¹ H.-H. Chen,¹ T.-W. Chen,¹ C.-C. Hsu,² M.-S. Wu.¹
Effect of Pylorus Preservation Procedure on Patient and Graft Outcome in Total Pancreatectomy with Islet Autotransplantation.

R. Shahbazov,¹ A. Dabous,² G. Yoshimatsu,² H. Fernandez,² G. Saracino,² B. Naziruddin,² N. Onaca,² P. Kim,² M. Levy.³
Effect of Telehealth Monitoring on Early Hospital Readmission After Renal Transplantation.

K. Noon,¹ N. Sarabu,¹ J. Augustine,¹ D. Hricik,¹ B. Deleva,¹ K. Woodside,² M. Aeder,¹ J. Foote,¹ A. Bruno,¹ K. Walsh,¹ M. Johnston,¹ V. Humphreville,¹ E. Sanchez.¹
Effect on Endothelial function when Hyperglycemia Is Reversed by Single Pancreas Transplantation.

T. Halden,^1,2 I. Eide,^1,2 D. Dahle,¹ A. Åsberg,^1,3 A. Reisæter,¹ T. Jenssen,^1,4 A. Hartmann.^1,2
Effects of Immunosuppression and Sun Exposure on Immune Cell Populations in Skin and Blood of Kidney Transplant Recipients.

M. Burke,¹ L. Nahum,⁴ N. Isbel,¹ R. Carroll,³ H. Soyer,¹ R. Francis,¹ J. Bridge,¹ C. Staatz,² J. Wells.¹
Efficacy and Renal Function in Kidney Transplant Recipients Receiving Tacrolimus (TAC)-Based Immunosuppressive Regimens in Combination with Everolimus (EVR) versus Mycophenolate (MPA).

A. Brigido, H. Tedesco, C. Felipe, M. Cristelli, M. Franco, J. Medina-Pestana.
Efficacy and Safety of Direct Antiviral Agents (DAA)-Based Therapies for Hepatitis C Virus (HCV) Infection in Kidney Transplant (KT) Recipients.

M. Fernandez Ruiz,¹ A. García Santiago,² N. Polanco Fernandez,² R. Muñoz,³ A. Hernandez,² E. González Monte,² V. Mercado,² I. Fernández,³ J. Aguado,¹ M. Praga,² A. Andrés.²